20S蛋白酶增强剂可以防止细胞毒性突蛋白聚合促进蛋白质诱导的α-synuclein聚合
Sophia D Staerz1,2, Charles Anamoah1, Jetze J Tepe1,2,3
1Department of Chemistry, Michigan State University, East Lansing, MI 48824, USA.
iScience
|July 8, 2024
概括
多系统性缩涉及细胞中的α-synuclein和p25α蛋白聚合物. 研究人员发现蛋白酶增强剂可以防止p25α诱导的α-synuclein聚合,恢复细胞功能和活力.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 细胞生物学 细胞生物学
- 蛋白质聚合蛋白质的聚合.
背景情况:
- 同核蛋白病变的特点是α-synuclein含有,其位置和组成决定了疾病模式.
- 在多重系统缩 (MSA) 中,包含在寡基细胞中,并含有p25α,这是一种对髓化至关重要的蛋白质.
- 异常的α-synuclein通过与p25α联合聚合来破坏寡类细胞的功能,导致细胞死亡.
研究的目的:
- 研究p25α在α-synuclein聚合中的作用及其对20S蛋白质组的影响.
- 确定可以减轻MSA中p25α诱导的神经退行症的治疗剂.
主要方法:
- 研究了p25α对20S蛋白质酶介导降解的敏感性.
- 研究了p25α对α-synuclein聚合和蛋白质组功能的影响.
- 选了增强20S蛋白酶体活性的小分子.
主要成果:
- 证明p25α被20S蛋白酶体降解.
- 表明p25α诱导α-synuclein聚合,损害蛋白酶体功能并导致细胞死亡.
- 确定了小分子蛋白酶体增强剂,可以防止p25α诱导的α-synuclein纤维化.
结论:
- 通过促进α-synuclein聚合和蛋白质酶功能障碍,p25α在MSA病变发生过程中发挥着关键作用.
- 小分子20S蛋白酶体增强剂通过恢复蛋白酶体活性和增强细胞活力来显示MSA的治疗潜力.
相关概念视频
01:13The Proteasome
827
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
827
01:45Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:42Microtubule Associated Proteins (MAPs)
4.3K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.3K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K